Ruggero Della Bitta MD, PhD, CMO

Dr. Della Bitta is board certified in Internal Medicine and Hematology and has more than 25 years of experience in oncology drug development. Prior to joining Precirix, Dr. Della Bitta was VP Product Development Oncology at Roche/Genentech in Basel. Earlier, he held positions in oncology clinical development and general management at Merck-Serono, Chiron and Quintiles/Iqvia. Prior to his industry experience, Dr. Della Bitta worked in the Medical Faculty at the University of Ancona in Italy and at the Cancer Institute in Milano.

Your browser is not supported. Update your browser for more security, speed and to make the most of this site.